The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

ViraferonPeg 2b 150 mcg / 0.5 ml 150 mcg ampoule

Schering Plough EuropeEU/1/00/132/047

Main Information

Trade NameViraferonPeg 2b 150 mcg / 0.5 ml 150 mcg ampoule
Active SubstancesPeginterferon alfa-2b
Dosage FormPowder and solvent for solution for injection
Licence HolderSchering Plough Europe
Licence NumberEU/1/00/132/047

Group Information

ATC CodeL03AB10 peginterferon alfa-2b


License statusAuthorised
Licence Issued06/02/2002
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back